Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

Malaria: esquizonte de Plasmodium sp. Liberando merozoitos

47,860 Aufrufe • vor 2 Jahren •via X (Twitter)

2 Kommentare

Profilbild von Hanne Brekke
Hanne Brekkevor 2 Jahren

I am a bit impressed and facinated by this 🤓

Profilbild von Daniel Alejandro
Daniel Alejandrovor 2 Jahren

@Sofrodriguez22

Ähnliche Videos

🚨 IVERMECTIN + MALARIA: THE "DOUBLE WHAMMY" AGAINST MOSQUITOES AND PLASMODIUM THAT'S GETTING ATTENTION Ivermectin is already known for targeting a broad range of parasites. But malaria presents a completely different challenge. The parasite doesn't simply live in the human body. It depends on a mosquito to keep the transmission cycle going. And that's where the Ivermectin story gets interesting. 🦟 FIRST TARGET: THE MOSQUITO Malaria is caused by Plasmodium parasites and transmitted by Anopheles mosquitoes. When a mosquito carrying Plasmodium bites, the parasite enters the bloodstream, moves into the liver, and eventually infects red blood cells. But what happens when that mosquito feeds on someone who has Ivermectin in their blood? Research highlighted in the video found a striking difference. After two days: Only around 52% of mosquitoes were still alive. Compared with: More than 97% when feeding on Ivermectin free blood. And there's another interesting detail. The mosquitoes stopped laying eggs. So the proposed effect isn't simply about killing individual mosquitoes. It could also interfere with their ability to reproduce. 🧬 SECOND TARGET: PLASMODIUM The story doesn't stop with the mosquito. The video also discusses evidence that Ivermectin can directly affect Plasmodium, the parasite responsible for malaria. Ivermectin may interfere with the parasite's ability to move substances in and out of its cells, potentially leading to parasite death. Some studies have also reported effects against both: • Sexual stages • Asexual stages of Plasmodium. 🌍 THE "DOUBLE WHAMMY" Instead of targeting only the parasite... Target the mosquito AND the parasite. That is the idea behind exploring Ivermectin for Mass Drug Administration, or MDA. MDA involves giving a medicine across a defined population to help control transmission. For MDA to make sense, several factors matter: Safety. Convenience. Cost. Ivermectin has decades of human use, is available as a tablet, and is generally inexpensive. The video highlights MDA approaches involving three days of Ivermectin administration each month. Then comes one of the most attention grabbing numbers. One research team estimated that: 📈 Three doses of Ivermectin over three months could reduce new malaria cases by 71%. The same estimate suggested overall malaria prevalence could fall by more than one third. The video also discusses children who received Ivermectin and experienced significantly higher hemoglobin levels, potentially indicating a lower parasite burden. And another trial in The Gambia reportedly produced even stronger results. The bigger idea is simple: Ivermectin may have the potential to attack malaria's transmission cycle from two directions. 🦟 The mosquito. 🧬 The Plasmodium parasite. That's the "double whammy." And with malaria continuing to require new tools, the possibility of using an established antiparasitic medicine to help reduce transmission is a research question worth watching. 📌 Save this if you're following Ivermectin, malaria, Plasmodium and antiparasitic research. 🔄️ Repost it so more people can see the research behind Ivermectin's potential role in malaria control. 💊 Looking for pharmaceutical grade Ivermectin? Discover quality Ivermectin from RXMEDS.STORE, trusted by thousands of customers worldwide. #Ivermectin #Malaria #IvermectinResearch #Plasmodium #Antiparasitic

RXMEDS.STORE

15,137 Aufrufe • vor 1 Monat